Cargando…

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series

BACKGROUND: Although dupilumab is an effective treatment approach for chronic actinic dermatitis (CAD) in some cases, its effectiveness and safety in CAD have not been sufficiently assessed. PURPOSE: Evaluation of the effectiveness and safety of dupilumab in patients with recalcitrant CAD was perfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiaoquan, Yu, Nanji, Wu, Weihong, Ou, Shanshan, Chen, Quan, Zhu, Huilan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474848/ https://www.ncbi.nlm.nih.gov/pubmed/37663886 http://dx.doi.org/10.2147/CCID.S422683

Ejemplares similares

Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature
por: Chen, Jiaoquan, et al.
Publicado: (2021)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Deng, Lin, et al.
Publicado: (2022)

Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
por: Arnold, Kathryn A., et al.
Publicado: (2018)

Clearance of Chronic Actinic Dermatitis With Dupilumab Therapy in Chinese Patients: A Case Series
por: Ali, Kamran, et al.
Publicado: (2022)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
por: Cho, Sung Kyung, et al.
Publicado: (2021)

Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series
por: Luo, Nana, et al.
Publicado: (2022)

Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019)

Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis
por: Esposito, Maria, et al.
Publicado: (2022)

The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy
por: Suresh, Raagini, et al.
Publicado: (2018)

JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
por: Shahriari, Neda, et al.
Publicado: (2023)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
por: Steinhoff, M., et al.
Publicado: (2021)

Meta-analysis of the efficacy of adding platelet-rich plasma to 308-nm excimer laser for patients with vitiligo
por: Chen, Jiaoquan, et al.
Publicado: (2022)

T-Cell Lymphoblastic Lymphoma with Cutaneous Involvement in a Child: A Rare Case Report
por: Chen, Jiaoquan, et al.
Publicado: (2022)

Remarkable response to dupilumab in a 5-year-old patient with severe, recalcitrant atopic dermatitis
por: Johnson, Brian B., et al.
Publicado: (2019)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021)

Effectiveness and safety of Dupilumab for the treatment at 104 weeks of recalcitrant bullous pemphigoid
por: Manzo Margiotta, Flavia, et al.
Publicado: (2023)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021)

Efficacy of NB-UVB as Add-on Therapy to Antihistamine in the Treatment of Chronic Urticaria: A Systematic Review and Meta-analysis
por: Chen, Jiaoquan, et al.
Publicado: (2021)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Topical tirbanibulin resolves recalcitrant condyloma acuminata: Retrospective case series
por: Moore, Angela Yen, et al.
Publicado: (2023)

Recalcitrant anal and genital pruritus treated with dupilumab()()()()
por: Yang, E.J., et al.
Publicado: (2018)

Recalcitrant prurigo nodularis treated successfully with dupilumab
por: Rambhia, Pooja H., et al.
Publicado: (2019)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
por: Abel, Mary Kathryn, et al.
Publicado: (2021)

Dupilumab monotherapy suppresses recalcitrant pemphigus vulgaris
por: Moore, Angela Y., et al.
Publicado: (2022)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
por: Avaylon, Jaycob, et al.
Publicado: (2020)

Dupilumab in HIV-positive patients: A case series report of 4 patients
por: Alawadhi, Ameen, et al.
Publicado: (2020)

The use of antivirals in severe or recalcitrant cases of pityriasis rosea: A case series
por: Tzur, Lihi, et al.
Publicado: (2022)

Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series
por: Slodownik, Dan, et al.
Publicado: (2022)

Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
por: MARESCHAL, Adrien, et al.
Publicado: (2020)

Recalcitrant generalized granuloma annulare treated successfully with dupilumab
por: Song, Eingun James, et al.
Publicado: (2020)

Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
por: Zhou, Albert E., et al.
Publicado: (2022)

Dupilumab for atopic dermatitis
Publicado: (2019)

Dupilumab for the treatment of severe photodermatitis
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab
por: Chen, Jiaoquan, et al.
Publicado: (2022)

Paederus Dermatitis: A Case Series
por: Srihari, Sahana, et al.
Publicado: (2017)

Systemic tacrolimus in the treatment of recalcitrant mucosal lichen planus
por: Chen, Edward, et al.
Publicado: (2017)

Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2021)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

Efficacy and safety of dupilumab in two adolescents with severe atopic dermatitis
por: Giavina-Bianchi, Mara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ajs8tig4g8j21shubrd93a7dtb